On the recordJuly 6, 2011
I was concerned about some of the restrictions that this committee placed on the advisory panels that advise the FDA about the approval or non-approval of drugs and devices.
Source
congress.govMichael Burgess: “I was concerned about some of the restrictions that this committee placed on the advisory panels that advise the FDA…”
Editor's note · Context
Burgess expresses concern over restrictions on FDA advisory panels affecting drug approvals.
Share
More from Michael Burgess
Sep 24, 2024
Last night, the House Committee on Rules met to report House Resolution 1486, providing for the consideration of four pieces of legislation. First, the rule provides for consideration of H. Res. 1469, condemning the Biden-Harris…
Dec 17, 2024
This has all been so moving and so lovely, but if anyone tuned in late tonight in C-SPAN, they probably thought I passed because it really did sound like a eulogy. I am still here, and I will continue to text and call and inform everyone…
Apr 16, 2024
I thank my friend for yielding. I rise today in support of this very important rule. Specifically, I rise in support of Israel following the attack on Israel by Iran this past weekend. This direct attack on Israel is unprecedented. It does…
Jul 9, 2024
I reserve the balance of my time. Mr. McGOVERN. Madam Speaker, may I inquire as to how much time is remaining. The SPEAKER pro tempore. The gentleman from Massachusetts has 4 minutes remaining. Mr. McGOVERN. Madam Speaker, is the gentleman…
Other voices in this conversation
